WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$85.99
−1.60%Forward multiples
Based on analyst estimates
- P/E forward
- 131.21x
- P/E 2026E
- 848.80x
- P/E 2027E
- 72.62x
- P/E 2028E
- 46.21x
- P/S forward
- 4.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.50x
- Price / sales
- 5.64x
- Price / cash flow
- -52.64x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 5.72x
- EV / EBITDA
- -34.01x
- EV / EBIT
- -42.89x
- Market cap
- $2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026